P2RY12 and myocardial infarction: DAPT with aspirin and a P2Y12 inhibitor reduces platelet activation and consequently the risk of stent thrombosis, leading to decreased myocardial infarctions and revascularizations—though at the expense of increased bleeding [1, 32].